Jacqueline Mercier is a partner in the firm’s Business Law Department and a member of Goodwin’s Technology and Life Sciences groups and a member of the Goodwin Life Sciences and Public Company Advisory practices. Ms. Mercier focuses her practice on late-stage and publicly traded company representation, including in matters related to corporate governance, mergers and acquisitions, royalty-based financings and other complex transactions, securities offerings, securities law compliance, proxy contests and general corporate matters. Ms. Mercier originally joined Goodwin in 2007.
Recent representative transactional matters include:
Ms. Mercier has also provided ongoing corporate governance and securities law advice to many of the firm’s late stage and public company clients, including Alkermes, Altos Labs, Amarin Corporation, AMAG Pharmaceuticals, Citrix Systems, Juvenescence, Kymera Therapeutics, Lionbridge Technologies, Novelion Therapeutics, Oxford Immunotec, Rubius Therapeutics, Vericel Corporation, Vigil Neuroscience and Zalicus.
Ms. Mercier is a member of the Massachusetts and Boston Bar Associations.
Ms. Mercier was named an Acritas Star for 2019. The annual global report honors lawyers who exemplify professional excellence, innovation, and collaboration in the legal profession, and is based on over 6,500 interviews with clients around the world.
While attending law school, Ms. Mercier was the Note Editor of the Boston College Third World Law Journal for which she wrote “Eliminating Child Marriage in India: A Backdoor Approach to Alleviating Human Rights Violations” (Winter 2006).
Upon graduating from law school, Ms. Mercier was the recipient of the Richard G. Huber Award for her scholarship and leadership in extra and co-curricular activities.
Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.
Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.
客户信赖我们世界一流的咨询服务，希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题，涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息，请与我们联系。
